Insider Transactions in Q4 2022 at Relmada Therapeutics, Inc. (RLMD)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 08
2022
|
Sergio Traversa Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
55,250
+27.73%
|
$110,500
$2.1 P/Share
|